IFNA1 and depressive symptom measurement: In this regard, our findings are consistent with those of Capuron et al (2003) and Schlaak et al (2012), who have demonstrated that cortisol responses and, respectively, gene expression changes, after the first injection of IFN-α, predict the development of depression after 12 weeks of treatment.